PI
ABBV icon

PEAK6 Investments’s AbbVie ABBV Stock Holding History

PEAK6 Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.81M Buy
14,248
+11,883
+502% +$2.22M 0.01% 1290
2024
Q2 		$406K Buy
+2,365
New +$392K ﹤0.01% 2367
2024
Q1 		– Sell
-13,858
Closed -$2.39M – 3927
2023
Q4 		$2.15M Sell
13,858
-6,426
-32% -$937K 0.01% 1460
2023
Q3 		$3.02M Sell
20,284
-67,681
-77% -$9.94M 0.01% 1047
2023
Q2 		$11.9M Buy
+87,965
New +$12.9M 0.05% 311
2023
Q1 		– Sell
-3
Closed -$459 – 4155
2022
Q4 		$550 Sell
3
-18,728
-100% -$2.87M ﹤0.01% 4298
2022
Q3 		$2.51M Sell
18,731
-75,862
-80% -$10.9M 0.01% 1358
2022
Q2 		$12.9M Buy
94,593
+94,590
+3,153,000% +$14.5M 0.02% 698
2022
Q1 		$1K Buy
+3
New +$436 ﹤0.01% 4982
2021
Q4 		– Sell
-42,738
Closed -$5.05M – 5019
2021
Q3 		$4.61M Buy
42,738
+40,980
+2,331% +$4.68M 0.01% 1215
2021
Q2 		$198K Buy
+1,758
New +$198K ﹤0.01% 4040
2021
Q1 		– Sell
-30,283
Closed -$3.24M – 4752
2020
Q4 		$3.25M Sell
30,283
-123,241
-80% -$11.8M 0.01% 1440
2020
Q3 		$13.4M Buy
153,524
+98,613
+180% +$9.28M 0.03% 463
2020
Q2 		$5.39M Sell
54,911
-66,568
-55% -$5.86M 0.02% 776
2020
Q1 		$9.26M Sell
121,479
-31,764
-21% -$2.71M 0.05% 330
2019
Q4 		$13.6M Buy
153,243
+47,622
+45% +$3.95M 0.07% 293
2019
Q3 		$7.88M Sell
105,621
-112,197
-52% -$7.69M 0.05% 463
2019
Q2 		$15.8M Buy
217,818
+184,736
+558% +$14.5M 0.11% 207
2019
Q1 		$2.67M Buy
+33,082
New +$2.71M 0.02% 1112
2018
Q4 		– Sell
-35,739
Closed -$3.14M – 3900
2018
Q3 		$3.38M Buy
+35,739
New +$3.39M 0.01% 1044

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PEAK6 Investments's ABBV Position: Q3 2024 in Review

PEAK6 Investments increased its AbbVie (ABBV) stake by 502% in Q3 2024, buying an estimated $2.22M and bringing the position to 14,248 shares worth $2.81M. The position accounts for 0.01% of the portfolio, ranked #1290.

PEAK6 Investments first reported a position in ABBV in Q3 2018 and has held it in 20 quarters since. The position peaked at $15.8M in Q2 2019. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • PEAK6 Investments held 14,248 shares of AbbVie worth $2.81M as of Q3 2024.
  • PEAK6 Investments bought 11,883 AbbVie shares in Q3 2024, an estimated $2.22M.
  • AbbVie made up 0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1290 holding.
  • PEAK6 Investments first reported a position in AbbVie in Q3 2018 and has held it in 20 quarters since.
  • PEAK6 Investments's AbbVie position peaked at $15.8M in Q2 2019.
  • 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.